TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bristol-Myers Squibb AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,925,787
|
3,479,462
|
2,892,362 |
| Financial expenses |
170
|
37,533
|
9,180 |
| Earnings before taxes |
196,211
|
0
|
191,483 |
| EBITDA |
197,148
|
4,619
|
204,953 |
| Total assets |
1,509,164
|
1,340,183
|
2,139,969 |
| Current assets |
1,496,223
|
1,325,779
|
2,120,254 |
| Current liabilities |
660,707
|
646,317
|
1,547,545 |
| Equity capital |
847,779
|
692,639
|
589,190 |
| - share capital |
6,703
|
6,585
|
6,148 |
| Employees (average) |
155
|
164
|
160 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.2%
|
51.7%
|
27.5% |
| Turnover per employee |
25,328
|
21,216
|
18,077 |
| Profit as a percentage of turnover |
5.0%
|
0%
|
6.6% |
| Return on assets (ROA) |
13.0%
|
2.8%
|
9.4% |
| Current ratio |
226.5%
|
205.1%
|
137.0% |
| Return on equity (ROE) |
23.1%
|
0%
|
32.5% |
| Change turnover |
383,587
|
381,867
|
461,612 |
| Change turnover % |
11%
|
12%
|
19% |
| Chg. No. of employees |
-9
|
4
|
7 |
| Chg. No. of employees % |
-5%
|
3%
|
5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.